04/16/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
7:33 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
7:33 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
7:35 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:01 AM | Monopar Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/07/2024
7:30 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
12:45 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
5:59 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
6:36 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:37 PM | Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:38 PM | KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:39 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:40 PM | Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:40 PM | Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:33 PM | Monopar Therapeutics (Issuer)
RIOUX PATRICE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:34 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:01 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
6:35 PM | Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:36 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:37 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:30 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:31 PM | Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:32 PM | Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:34 PM | KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
4:16 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
5:45 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
5:46 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
5:46 PM | Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
5:49 PM | KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
5:49 PM | Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
2024's Must-Have Guide: Master Crypto Investment Today (Ad) The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters?
Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors.
(**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.) Click here to download your crypto report |
07/03/2023
5:50 PM | Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
5:51 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
6:01 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:01 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
6:03 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
3:50 PM | Monopar Therapeutics (Filer)
| Form ARS | |
